Evidence for the human carcinogenic effects of alcohol consumption on the risk of cancers of the oral cavity and pharynx has been considered sufficient in the International Agency for Research on Cancer Monograph 44 on alcohol and cancer in 1988. We evaluated human carcinogenic evidence related to the risk of oral and pharyngeal cancers based on cohort and case-control studies published from 1988 to 2009. A large body of evidence from epidemiological studies of different designs and conducted in different populations has consistently supported the fact that alcohol consumption is strongly associated with an increase in the risk of oral and pharyngeal cancers. The relative risks are 3.2-9.2 for more than 60 g/day (or more than four drinks/day) when adjusted for tobacco smoking and other potential confounders. A strong dose-response effect on the intensity of alcohol use is reported in most of the studies. However, no apparent association is observed for the duration of alcohol use. Compared with current alcoholics, a decreased risk of approximately 10 to 15 years is associated with alcohol cessation. Similar associations have been observed among nonsmokers in over 20 studies. In general, the dominant type of alcohol consumption in each population is associated with the greatest increase in risk. A large number of studies on joint exposure to alcohol and tobacco consumption show a greater than multiplicative synergistic effect.
Introduction
The evidence of the human carcinogenic effects of alcohol consumption on the risk of cancers of the oral cavity and pharynx was considered sufficient in the International Agency for Research on Cancer (IARC) Monograph 44 in 1988 (IARC Working Group, 1988 . In this review, we evaluate human carcinogenic evidence related to oral and pharyngeal cancers based on cohort and case-control studies published since 1988. PubMed searches were conducted for the period between 1988 and 2009 using the following key words in various combinations: 'alcohol', 'ethanol', 'beer', 'wine', 'liquor', 'oral cancer', 'pharyngeal cancer', 'oropharyngeal cancer'. We also reviewed the references cited by each article for possible additional studies. We included all 12 cohort studies during this time period and case-control studies that met the following criteria: (i) published as an original article; (ii) had a total sample size (cases and controls) of at least 100; (iii) reported quantitative levels of alcohol consumption or had at least three levels of alcohol consumption. When data on the study populations were published multiple times, the latest study was included. Among 44 casecontrol studies, 13 had data on cancer of the oral cavity, 13 of the pharynx, and 26 of the oral cavity and pharynx combined.
For comparability, one drink is equivalent to 14 g, 18 ml, or 0.49 oz of alcohol, which generally corresponds to 330 ml of beer, 150 ml of wine, and 36 ml of hard liquor. Cancers of the oral cavity and pharynx are predominantly squamous cell carcinomas. The composition of the tumors is given where available in the papers reviewed during this period. In general, studies on pharyngeal cancers are predominantly oropharyngeal and hypopharyngeal, rather than nasopharyngeal. Two case-control studies, however, specifically concentrate on nasopharyngeal cancer.
Studies are summarized in five tables. Table 1 presents the cohort studies. Table 2 summarizes the case-control studies on cancers of the oral cavity, pharynx, and oral cavity and pharynx combined. Studies that focus on specific alcohol types are shown in Table 3 . Studies on the combined or joint effects of alcohol and tobacco smoking are displayed in Table 4 . The associations among nonsmokers are presented in Table 5 . The risks associated with duration of alcohol use and the effects of alcohol cessation are summarized across the five tables. 0.2-1.0 0.5-1.9 1.2-4.0 1.7-6.1 1.0-6.8 3.7-10.1 1.1-3.5
Age, smoking Adami et al. (1992) Uppsala, Sweden Day et al. (1994) USA Nested case-control study of second primary cancers; cohort of 1090 first primary cancers of oral cavity and pharynx; enrollment of first primary cancers in 1984-1985; follow-up until 1989; 80 (56 men, 24 0.5-5.1 0.7-6.6 0.5-4.5 1.6-18.0 0.6-6.7
Age at first cancer diagnosis, stage of first cancer, lifetime smoking Nested case-control study among cases of Blot et al. (1988) study; looked at type of alcohol and cessation of alcohol Chyou et al. (1995) Hawaii, USA 1.1-71.0 Murata et al. (1996) Japan
Nested case-control study; cohort of 17 200 men part of a gastric mass screening survey in 1984; incidence follow-up until 1993; two controls per case; matched on sex,
birth-year, city/county Self-administered questionnaire Oral cavity, pharynx, esophagus, 161) Total alcohol (cups/day) 0 0.1-1.0 1.1-2.0 2.1 + w 2 for trend 17 13 11 10 1.0 1.0 1.9 9.0 9.6 NA NA NA NA P < 0.01
Unit is cup of 180 ml of sake: corresponds to 27 ml of ethanol; looked at joint effects with smoking Kjaerheim et al. (1998) Norway Cohort of 10 960 men born from 1893-1929 who completed two questionnaires sent to a probability sample of the Norwegian population; incidence follow-up 1968-1992 Mailed survey Oral cavity, pharynx, larynx, esophagus (ICD7 141, (143) (144) (145) (147) (148) 150, 161) Total alcohol (times/week) Never or < 1 Earlier 1-3 4-7 P for trend 26 4 18 19 1.0 0.9 1.1 3.9 0.3-2.7 0.6-1.9 2.1-7.1 0.003
Age, smoking
Looked at type of alcohol Sorensen et al. Looked at joint effects with smoking Dikshit et al. (2005) Switzerland, France, Italy, Spain
Occurrence of second primary tumors among a cohort of 876 male cases of laryngeal/ hypopharyngeal cancer from a multicentric population-based case-control study (1979) (1980) (1981) (1982) [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1992] [1993] [1994] [1995] [1996] [1997] Oral cavity and pharynx 137 cases (113 men, 24 women) from Milan and Pordenone, Italy (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) and Vaud, Switzerland (1992 consumption and oral-pharyngeal cancers (Boffetta and Garfinkel, 1990; Chyou et al., 1995; Murata et al., 1996; Kjaerheim et al., 1998; Boeing, 2002) . Four studies reported smoking-adjusted relative risks (RRs), whereas one did not (Murata et al., 1996) . Increases in risk with alcohol consumption are observed in all five studies with various study populations from the USA, Europe, and Asia. The adjusted RRs [and 95% confidence intervals (CIs)] are 9.22 (2.75-30.93) for more than 60 g/day (or more than four drinks/day) in an European population (Boeing, 2002) ; 3.24 (1.72-6.08) for more than four drinks/day in the American Cancer Society (ACS) prospective study (Boffetta and Garfinkel, 1990) ; and 3.9 (2.1-7.1) for 4-7 times per week in a study in Norway (Kjaerheim et al., 1998) . A strong dose-response relationship is observed in three studies (Murata et al., 1996; Kjaerheim et al., 1998; Boeing, 2002) , whereas two studies found a J-shaped relationship with a reverse association at low alcohol consumption levels (Boffetta and Garfinkel, 1990; Chyou et al., 1995) . Increases in the risk of alcohol consumption are consistently observed in studies, regardless of adjustment for smoking.
Five special population cohort studies on alcoholics or alcohol abstainers were published during the review period (Adami et al., 1992; Kjaerheim et al., 1993; Tonnesen et al., 1994; Sigvardsson et al., 1996; Sorensen et al., 1998) . These types of studies usually do not consider the individual exposure level. The point estimates are either the standard incidence ratios or standard mortality ratios without adjusting for tobacco smoking. Among cohorts of alcoholics, an increase in risk for cancers of the oral cavity and pharynx has been shown when compared with either the local population rate (Adami et al., 1992; Tonnesen et al., 1994; Sorensen et al., 1998) or a general population rate (Sigvardsson et al., 1996) . Adami et al. (1992) found a fourfold increase in risk (95% CI: 2.9-5.6) for oral cavity and pharyngeal cancers among Swedish alcoholics. Tonnesen et al. (1994) also found an increase of over 3.5-fold in risk (95% CI: 3.0-4.3) for oral cavity and pharyngeal cancers among men and a 17-fold increase (95% CI: 10.8-26.0) among women. Sorensen et al., 1998 found a nine-fold increase in risk (95% CI: 7.8-10.8) for oral cavity and pharyngeal cancers when compared with national incidence rates of 1-year survivors of cirrhosis among Danish alcoholics. Furthermore, the risk was increased over 11-fold (95% CI: 9.6-14.0) in alcoholic cirrhosis patients, but only 4-fold (95% CI: 1.8-8.2) among hepatitis cirrhosis patients. In contrast, a cohort of members of the International Organization of Good Templars in Norway, where members sign a statement that they will abstain from alcohol, showed a 56% decrease in risk (standard incidence ratios 95% CI: 0.09-1.27) for oral cavity and pharyngeal cancers when compared with the national rates (Kjaerheim et al., 1993) .
Alcohol has also been associated with second primary cancers of the oral cavity and pharynx in two cohorts of patients with a first primary cancer (Day et al., 1994 ; Merletti et al. (1989) Torino, Italy, 1982 Italy, -1984 Oral cavity and oropharynx 141, (143) (144) (145) (146) 1-20 cigarettes/day 1.5 (0.9-2.5) 5.8 (3.7-9.1) 11.9 (7.7-18.4) 21-30 cigarettes/day 2.2 (1.1-4.3) 6.8 (3.6-12.7) 13.5 (7.9-23.2) 31 + cigarettes/day 2.0 (1.1-3.7) 6.9 (3.9-12.4) 20. [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1992] [1993] [1994] [1995] [1996] [1997] Oral cavity and pharynx Dikshit et al., 2005) . Day et al. (1994) and Dikshit et al. (2005) observed an increase in risk of second primary cancers, although a dramatic increase was found among Europeans [3-fold to 3.5-fold increase in risk among those consuming 81 + g/day (Dikshit et al., 2005) ] over Americans (1.5-fold increase in the risk among those consuming 60 + g/day) (Day et al., 1994) , which may be attributed to the differences in exposure intensity.
Results from prospective cohort studies of the general population provide sufficient evidence of the significant role of alcohol consumption in the development of oral and pharyngeal cancers. The strength of the association is shown by significantly increased RRs, ranging from 3 to 9. A strong dose-response relationship was observed in almost all studies. The association was observed across different geographical regions and populations, which further supports the evidence.
Case-control studies: data in Table 2 Cancer of the oral cavity
All of the eight studies on oral cancer were hospital-based case-control studies Zheng et al., 1990; Choi and Kahyo, 1991; Zheng et al., 1997; Rao and Desai, 1998; Balaram et al., 2002; Znaor et al., 2003; De Stefani et al., 2007) , and all but one (Rao and Desai, 1998) adjusted for tobacco smoking when evaluating alcohol exposure. Studies on cancers of the entire oral cavity observed an association with a dose-response relationship between alcohol consumption and oral cancer in different geographical areas of the world Zheng et al., 1990; Choi and Kahyo, 1991; Balaram et al., 2002; Znaor et al., 2003; De Stefani et al., 2007) . Among two studies of tongue cancer only (Zheng et al., 1997; Rao and Desai, 1998) , Rao and Desai (1998) observed increased risks with alcohol consumption of once per day [odds ratio (OR) = 1.5 (0.9-2.5) and 1.5 (1.1-2.3) for anterior tongue and base tongue, respectively]; when consuming alcohol twice a day, the increase in risk rises for the anterior tongue [OR = 3.7 (1.7-10.8)] but drops close to baseline [OR = 1.1 (0.4-3.1)] for the base tongue. No trend was found in the study of tongue cancer with a limited sample size (Zheng et al., 1997) .
Overall, increase in the risk of oral cancer associated with alcohol consumption is substantial, even after controlling for smoking. The strength of the association was shown by elevated adjusted ORs for heavy alcohol consumption ranging from 2 to 14 and a dose-response relationship was observed in most studies with multiple exposure levels. The association has been observed across different geographical regions and populations, which further supports the role of alcohol consumption in oral carcinogenesis.
Cancer of the pharynx
Among the nine studies on cancer of the pharynx, three were population-based (Tuyns et al., 1988; Nam et al., 1992; Cheng et al., 1999) and six were hospital-based Choi and Kahyo, 1991; Maier et al., 1994; Znaor et al., 2003; De Stefani et al., 2004 . All studies were adjusted for or stratified by tobacco smoking. All studies showed strong associations with alcohol consumption, except for one study on nasopharyngeal cancer in Taiwan (Cheng et al., 1999) . A possible explanation for the lack of association in this study may be the categorization of exposure, with the highest exposure group of greater than or equal to 15 g/day (equivalent to just over one drink/ day), which may be too low to detect an association. The other study on nasopharyngeal cancer by Nam et al. (1992) , however, showed an increase in the risk with heavy alcohol consumption (24 + drinks/week) [OR = 1.9 (1.1-3.2) for men; OR = 7.3 (2.1-32.5) for women].
Alcohol consumption was associated with an increase risk of cancers of the oropharynx and hypopharynx across different geographical regions and populations with the point estimates of adjusted ORs ranging from 3 to 12, as was the case for oral cancer. All studies observed a strong dose-response trend between increasing alcohol consumption and risk.
Risk associated with type of alcoholic beverage: data in Table 3 Assessment of different types of alcoholic beverages is a complicated task; alcoholics rarely consume only one type of alcohol, and isolating the effects of a single type in the presence of the other types is difficult to accomplish. In some populations, most of the alcoholics consume only one major type of alcoholic beverage, which makes it more difficult to detect any potential difference across different types Zheng et al, 1990; Zheng et al., 1997) . Heterogeneity of effects across different populations adds more difficulty in interpreting results. Overall, among studies in the USA, the ranking from highest-to-lowest-risk alcohol type is beer, hard liquor, and wine (Mashberg et al., 1993; Day et al., 1994; Kabat et al., 1994; Blot et al., 1988) . In European studies among Italian and Swiss populations, the highest risk is associated with wine consumption Barra et al., 1991; Altieri et al., 2004) , whereas in a Swedish population, the highest risk is associated with beer and liquor (Schildt et al., 1998) . In Latin America, hard liquor is associated with the highest risk among Cuban (Garrote et al., 2001) and Brazilian populations (Schlecht et al., 2001) , and wine among Uruguayans (De Stefani et al., 2004 . In India, arrack, a popular type of hard liquor in South and Southeast Asia, is associated with the highest risk (Znaor et al., 2003) .
In several studies, the other types of alcoholic beverages are not controlled for, which may distort the association. In general, the dominant types of alcohol are associated with the greatest increases in risk. The hypothesis that ethanol and its metabolites are the principal carcinogenic agents in alcoholic beverages, rather than beverage-specific constituents, has also been supported by a pooling project, the International Head and Neck Cancer Epidemiology (INHANCE) Consortium with 15 case-control studies (Purdue et al., 2009) . This pooled analysis included 858 cases and 986 controls of alcoholics consuming beer only, 499 cases and 527 controls of alcoholics consuming liquor only, 1021 cases and 2460 controls of alcoholics consuming wine only, and 1124 cases and 3487 controls of nonalcoholics. Comparable results for ethanol-standardized consumption among alcoholics consuming beer only (ORs = 1.6, 1.9, 2.2, and 5.4 for r 5, 6-15, 16-30, and > 30 drinks/week, respectively; P trend < 0.0001), alcoholics consuming liquor only (ORs = 1.6, 1.5, 2.3, and 3.6; P < 0.0001), and alcoholics consuming wine only (ORs = 1.1, 1.2, 1.9, and 6.3; P < 0.0001) were observed.
Studies on combined or joint effects with tobacco: data in Table 4 The joint effects of alcohol and smoking on cancers of the oral cavity and pharynx have been evaluated extensively. These studies varied in their methods and approaches for assessing effect modification, ranging from descriptive to formal estimation of interaction terms in multivariate models.
The evidence comes almost entirely from case-control studies carried out in Asia, Australia, Europe, and the USA. Three prospective cohort studies have reported joint effects between alcohol and tobacco exposures, including the European Prospective Investigation into Cancer and Nutrition study (Boeing, 2002) , a cohort study of Japanese men in Hawaii (Chyou et al., 1995) , and a nested case-control study from a cohort of male participants in a gastric mass screening survey in Japan (Murata et al., 1996) . Overall, a majority of studies on exposure to both alcohol and tobacco consumption show a joint effect (Blot et al., 1988; Tuyns et al., 1988; Merletti et al., 1989; Franceschi et al., 1990; Zheng et al., 1990; Maier et al., 1992; Nam et al., 1992; Mashberg et al., 1993; Kabat et al., 1994; Chyou et al., 1995; Murata et al., 1996; Sanderson et al., 1997; Zheng et al., 1997; Schildt et al., 1998; Franceschi et al., 1999; Hayes et al., 1999; Schlecht et al., 1999; Garrote et al., 2001; Schwartz et al., 2001; Boeing, 2002; Znaor et al., 2003; Castellsague et al., 2004; Rodriguez et al., 2004; De Stefani et al., 2004 , including the INHANCE Consortium, which reported a greater than multiplicative joint effect between tobacco and alcohol use [OR interaction = 2.15 (1.53-3.04)] ). The population-attributable risk for tobacco and alcohol was 72% (4% for alcohol, 33% for tobacco alone, and 35% for tobacco and alcohol combined).
Effect of alcohol in nonsmokers: data in Table 5 As tobacco smoking is a major risk factor for oral and pharyngeal cancers, evaluation of the effect of alcohol among nonsmokers will avoid a strong confounding effect by tobacco smoking. An increase in risk of alcohol exposure is consistently observed among nonsmokers. Fioretti et al. (1999) reported a three-fold increase in the risk for cancers of the oral cavity and pharynx among alcoholics compared with nonalcoholics in Italy. Talamini et al. (1990) reported a significant dose-response relationship between alcohol and cancers of the oral cavity and pharynx in 27 cases and 572 controls (P = 0.04) in Italy. Ng et al. (1993) observed a strong dose-response relationship among men (P < 0.001) in the USA. A dose-response relationship was seen between alcohol and cancers of the oral cavity and pharynx in 60 nonsmoking cases and 692 controls (P = 0.01) from Italy and Switzerland (Talamini et al., 1998) . The pooling project from the INHANCE Consortium (Hashibe et al., 2007) , including 383 oral cancer, 369 oropharyngeal or hypopharyngeal cancer, 155 oral or pharyngeal (not otherwise specified) cancer cases, and 5 775 controls, observed a significant dose-response relationship for oropharyngeal and hypopharyngeal cancers and frequency of alcohol consumption (P < 0.001). The adjusted ORs were 1.66 (1.18-2.34) for 1-2 drinks/ day, 2.33 (1.37-3.98) for 3-4 drinks/day, and 5.50 (2.26-13.36) for 5 + drinks/day. The association was weaker for cancers of the oral cavity.
In addition, among the studies on effect modification by tobacco listed in Table 4 , the effect of alcohol consumption among nonsmokers was presented in 18 studies (Blot et al., 1988; Merletti et al., 1989; Franceschi et al., 1990; Zheng et al., 1990; Kabat et al., 1994; Chyou et al., 1995; Murata et al., 1996; Sanderson et al., 1997; Zheng et al., 1997; Schildt et al., 1998; Franceschi et al., 1999; Hayes et al., 1999; Schlecht et al., 1999; Garrote et al., 2001; Schwartz et al., 2001; Boeing, 2002; Znaor et al., 2003; Castellsague et al., 2004) . The majority of these studies found a strong association with alcohol consumption among nonsmokers with a dose-response relationship, which is supportive evidence for the carcinogenic effects of alcohol consumption.
Risk associated with duration of alcohol use
The evaluation of risk from the duration of alcohol consumption comes entirely from case-control studies.
Most of the studies found no clear trend Zheng et al., 1997; Rao and Desai, 1998; Cheng et al., 1999; Franceschi et al., 2000; Garrote et al., 2001) on oral cavity and pharyngeal cancers, except for one study in India (Znaor et al., 2003) , one in Spain (Castellsague et al., 2004) , and two studies in Uruguay (De Stefani et al., 2004 , in which dose-response relationships were observed (Table 2 ). In addition, no apparent association was observed for the duration of alcohol use and the risk of head and neck cancer among nontobacco users in the INHANCE study (Hashibe et al., 2007) (Table 5 ).
Risk and alcohol cessation
Case-control studies of alcohol cessation may be affected by protopathic bias (reverse causality bias) because the precursors and early malignancies of the oral cavity and pharynx may lead to alcohol cessation. Nevertheless, this may result in an underestimation of the effect of alcohol cessation. The risk of oral and pharyngeal cancers has been higher in current alcoholics than in former alcoholics (Zheng et al., 1990; Mashberg et al., 1993; Zheng et al., 1997; Garrote et al., 2001; Schlecht et al., 2001; Balaram et al., 2002; Castellsague et al., 2004; De Stefani et al., 2004 , except in one study that did not find an association with nasopharyngeal cancer (Cheng et al., 1999) [Schlecht et al. (2001) in Table 3 ; the others in Table 2 ]. For recent quitters, risk for oral and pharyngeal cancers either increases or remains the same as that of current alcoholics. As the number of years since quitting increases, however, the risk gradually drops, below the risk of current alcoholics and near the levels of nonalcoholics in three studies of over 10 years (De Stefani et al., 2004) , after 14 years (Castellsague et al., 2004) , and after 20 years of quitting (Hayes et al., 1999) (Table 2 ). However, Day et al. (1994) and Franceschi et al. (2000) , in contrast, observed that a reduction in risk is not attained after 5 or even 11 years of quitting, respectively (Tables 1 and 2) .
The INHANCE Consortium (Marron et al., 2009) with an analysis of 13 case-control studies reported beneficial effects of alcohol cessation after quitting for 20 years or longer [OR = 0.45 (0.26-0.78) for oral cancer; OR = 0.74 (0.50-1.09) for oropharyngeal and hypopharyngeal cancer, compared with current alcoholics] (Table 2) .
Conclusion
The evidence for the human carcinogenic effects of alcohol consumption on the risk of cancers of the oral cavity and pharynx has been considered sufficient in the IARC Monograph 44 on alcohol and cancer in 1988 (IARC Working Group, 1988) , and in the more recent IARC Monograph 96 (Baan et al., 2007) . The human carcinogenic evidence related to oral and pharyngeal cancer risk in this review is based on relevant publications after 1988.
Increases in risk with alcohol consumption are observed in all five cohort studies with study populations from the United States, Europe, and Asia. Heavy alcohol consumption is associated with a significantly increased risk in all five studies, regardless of whether cigarette smoking was controlled. Five special population cohort studies observed a statistically significant association between alcohol consumption and oral-pharyngeal cancers. Four studies of alcoholics showed positive associations and one study in members of the International Organization of Good Templars in Norway (lower alcohol consumption) showed a 56% decrease in risk. For case-control studies, all six studies of oral cancer, eight of nine studies of pharyngeal cancer, and 17 of 19 studies reported statistically significant associations between alcohol consumption and risk of oral-pharyngeal cancers. Almost all studies controlled for tobacco smoking.
The independent effect of alcohol consumption on the risk of oral and pharyngeal cancers occurs across different geographical locations and populations in the world, especially among over 20 studies of nonsmokers. The risk increases with increased amounts of alcohol consumption in the majority of these studies. A meta-analysis of studies published until 2000, including 7954 cases, estimated RRs of 1.75 (1.70-1.82) for 25 g/day, 2.85 (2.70-3.04) for 50 g/day, and 6.01 (5.46-6.62) for 100 g/ day (Bagnardi et al., 2001 ). An update of that work to 2009 gave RRs of 1.21 (1.10-1.33) for one drink/day or less and 5.24 (4.36-6.30) for at least four drinks/day (Tramacere et al., 2010) .
The dominant alcohol types in a specific region are associated with the greatest increased risk. A large number of studies on joint exposure to alcohol and tobacco show a synergistic effect. Most studies reported no association between duration of alcohol use and the risk of oralpharyngeal cancers. Compared with current alcoholics, reduced risk was associated with alcohol cessation for more than 10 years.
Alcohol and oral-pharyngeal cancer Goldstein et al. 463
In conclusion, results from a substantial number of epidemiological studies with different designs from different geographical regions provide sufficient evidence and confirm the 1988 IARC Working Group's conclusion that alcohol consumption is carcinogenic, and can cause oral and pharyngeal cancers.
